World News Insights
1-3 Minute Gist
Support LyrArc
Reader contributions keep LyrArc open for everyone
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Browse Articles or use Lyrarc's US patented "Groups" and "Links" for new insights. A Lyrarc Group of Articles on a topic gives insights into particular angles shown in the Group Title. A Lyrarc Link shows more specific insights for 2 articles.
All Topics Articles
LyrArc brings in selected articles from many of the world's top publications.
Articles are selected by experts and you can see the gist of the important articles.
LyrArc Article Gist
France and Britain support president Biden in removing vaccine patent barriers so that vaccine production can be ramped up.
France and Britain support president Biden in removing vaccine patent barriers so that vaccine production can be ramped up.
LyrArc Article Gist
The Oxford vaccine is to be combined with a dose of Russia's Sputnik vaccine in a study to determine if this will provide improved results. The idea is to test whether two doses combined of Oxford and Sputnik vaccine can provide better protection than two doses of the same vaccine. Trials will begin by the end of 2020. This is being done under the concept of heterologous prime boost which has been adopted in vaccination programmes against other diseases.
,Both the Russian and the Oxford vaccine use a modified version of adenovirus, a common cold virus. This is stripped of disease causing genes and given genetic instructions that make the coronavirus cause a spike in the protein when it passes it to the human cells. This then triggers an immune response.
The Oxford vaccine is to be combined with a dose of Russia's Sputnik vaccine in a study to determine if this will provide improved results. The idea is to test whether two doses combined of Oxford and Sputnik vaccine can provide better protection than two doses of the same vaccine. Trials will begin by the end of 2020. This is being done under the concept of heterologous prime boost which has been adopted in vaccination programmes against other diseases.
,Both the Russian and the Oxford vaccine use a modified version of adenovirus, a common cold virus. This is stripped of disease causing genes and given genetic instructions that make the coronavirus cause a spike in the protein when it passes it to the human cells. This then triggers an immune response.
LyrArc Article Gist
General practitioner physician in Edinburgh, Gavin Francis, describes the mental health issues that are now common. He says they come in the form of panic and anxiety that are leaching into everyone's lives like a second pandemic.
General practitioner physician in Edinburgh, Gavin Francis, describes the mental health issues that are now common. He says they come in the form of panic and anxiety that are leaching into everyone's lives like a second pandemic.
Read LyrArc gist ›
Original article 1 minute, gist 1 minute
Original article 1 minute, gist 1 minute
LyrArc Article Gist
Japan, the US and the EU are lagging behind in electric car manufacturing as China moves ahead, as shown here in the NYT.
Japan, the US and the EU are lagging behind in electric car manufacturing as China moves ahead, as shown here in the NYT.
LyrArc Article Gist
The economies of Lebanon, Jordan and Egypt dependent on 12-26% of earnings from abroad on tourism are hit by the war in Gaza. Israeli tourism is also affected with only half of the flights going in. Egypt was a bright spot after the pandemic faded with a strong recovery above that of pre pandemic levels. In 2023 Egypt expected to see 15 million tourists.
The economies of Lebanon, Jordan and Egypt dependent on 12-26% of earnings from abroad on tourism are hit by the war in Gaza. Israeli tourism is also affected with only half of the flights going in. Egypt was a bright spot after the pandemic faded with a strong recovery above that of pre pandemic levels. In 2023 Egypt expected to see 15 million tourists.
LyrArc Article Gist
US workers quit 5.6 million fewer jobs in the first 11 months of 2024, a 12% decline, compared to 2023. This suggests fewer job opportunities than previously. Most of the job creation in 2023 was in three sectors leisure hospitality, government and healthcare with unemployment rate at 3.7%.
US workers quit 5.6 million fewer jobs in the first 11 months of 2024, a 12% decline, compared to 2023. This suggests fewer job opportunities than previously. Most of the job creation in 2023 was in three sectors leisure hospitality, government and healthcare with unemployment rate at 3.7%.
LyrArc Article Gist
A three part series in the NYT on the speed, challenges and ways in which the American economy is moving towards Clean Energy.
A three part series in the NYT on the speed, challenges and ways in which the American economy is moving towards Clean Energy.
Support LyrArc
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Copyright © 2006 - 2026 Intelilinks LLC
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us